Delivery Order SPE2DB20D3103-SPE2DB22FN4H1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $18,066.00 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of TWINRIX Vaccine Syringes. The contract has an ultimate completion date of June 16, 2022 and was awarded on June 15, 2022. Amerisourcebergen is a major pharmaceutical distributor that supports federal healthcare programs, particularly within the Department of Defense and Department of Veterans...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) with a Firm Fixed Price of $2,870.14. The contract, which has no set-aside designation, is for the delivery of TWINRIX VACCINE SYRINGEML and has a completion date of March 17, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,079.30 for the supply of the Twinrix vaccine. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 15, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of TWINRIX VACCINE SYRINGEML. The $5,174.14 firm-fixed price delivery order, which has an ultimate completion date of February 13, 2025, does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $3,314.40, is for the delivery of the TWINRIX VACCINE SYRINGE ML product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2024. The award was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,584.28 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEMLs. The award was made on May 6, 2022, with a completion date of May 9, 2022, and did not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $5,388.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance through September 7, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $14,793.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes and has a completion date of May 19, 2023. The contract is a Firm-Fixed-Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $118,031.20 delivery order is for the supply of TWINRIX vaccine syringes. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999...
- This federal contract award, valued at $1,236.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of TWINRIX VACCINE SYRINGEML and has a firm fixed-price pricing type with an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN4H1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $177,856.40 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 4556976003 TWINRIX VACCINE SYRINGEML. The award has an ultimate completion date of April 25, 2022 and was made without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, as well as with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000.00. These IDCs enable Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $177.9k | 4/22/22 |